IAG Cargo’s Constant Climate product, which specializes in cold-chain pharmaceutical traffic, is ten years old this month, with consistent double-digit volume growth, year-over-year, and more than 35,000 shipments annually. IAG credited surging global pharmaceutical business as a major driver of its success, with sales in the industry projected to reach US$1.3 trillion by 2018. Such shipments require strict temperature controls and timely shipments, often around the world, which the Constant Climate products caters to.
Currently, 110 “Quality Approved Stations” around the world comprise IAG Cargo’s global Constant Climate network. Alan Dorling, global head of pharmaceuticals and life sciences at IAG Cargo, said the network has “transported critical vaccines at times of pandemic” and is “continually entrusted with high-value temperature-sensitive medicines,” which includes insulin and various oncology drugs.
IAG Cargo has expanded its network in Latin America, with two facilities opening in late 2015. However, the carrier said it is facing “challenging market conditions.” Second quarter numbers showed that IAG Cargo’s volumes were flat, while yields decreased 13.4 percent at constant exchange rates.
Join us for networking and discussion of logistics innovation at Air Cargo World’s new ELEVATE 2016 Conference, Oct. 10, in Miami.